OpenText Information Management
NOVEMBER 21, 2022
Pharmaceutical organizations in the life sciences industry face challenges in developing and maintaining data integrity due to complex validation documentation. Maintaining data consistency, accuracy, and integrity across many documents is challenging.
Gimmal
FEBRUARY 1, 2024
The new collaboration is off to a great start with its first successfully completed joint solution delivery for a top, leading global pharmaceutical company. NNIT has deep life sciences expertise, specifically within the compliance and validation arena, so we know how important it is to document and keep immaculate records.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AIIM
APRIL 6, 2021
This may already the reality for some leading companies, but for most organizations, forms, contracts, agreements, and signoffs are still rooted in wet ink on paper. Just think of how efficiency increases when the paper is removed! It’s this simple distinction that unlocks the true power of Digital Signatures.
Security Affairs
OCTOBER 3, 2020
The attackers primarily ran malicious ad campaigns, often in the form of advertising pharmaceutical pills and spam with fake celebrity endorsements.” ” continues the paper. . “Our investigation uncovered a number of interesting techniques used to compromise people with the goal to commit ad fraud.
The Last Watchdog
APRIL 29, 2019
With so much at stake, it’s a marvel that AD disaster recovery protocol traditionally has been based on a 60-page white paper that needs to be manually followed. pharmaceutical giant Merck; the crippling of its AD tool resulted in suffering drug shortages and losing hundreds of millions of dollars ( latest estimation is 870 million ).
The Last Watchdog
MARCH 17, 2021
Biomedical engineer Dr. Joe Alexander, the former medical director at pharmaceutical giant Pfizer, grabbed a distinguished scientist post, as well. The result is that commercial deployment, or the productization, if you will, of tiers of diligent basic research are on the near horizon.
IT Governance
SEPTEMBER 4, 2018
For life sciences and pharmaceutical companies, this includes data on the development and testing of new therapies and details of how therapies are manufactured. IP includes sensitive business or trading information and research and development information. The risk of losing your IP.
Expert insights. Personalized for you.
67 
Let's personalize your content